Financial Data and Key Metrics Changes - CareCloud reported Q3 2025 revenue of $31.1 million, a 9% increase from the same period last year, with GAAP EPS improving by $0.08 year-over-year to $0.04 [6][31] - Adjusted EBITDA increased 13% to $7.7 million, demonstrating operating leverage in the business model [6][31] - Full-year revenue guidance was raised to $117-$119 million, up from the previous guidance of $111-$114 million [5][13] Business Line Data and Key Metrics Changes - CareCloud Wellness generated approximately $900,000 in revenue for Q3 and about $2.6 million for the first nine months of 2025 [30] - The MedSphere acquisition contributed approximately $3.4 million in revenue for Q3, enhancing CareCloud's capabilities in the hospital market [30] Market Data and Key Metrics Changes - The company is now positioned to serve community hospitals, regional systems, and critical access hospitals, expanding its market reach significantly [8][9] - The acquisition of MapApp allows CareCloud to provide benchmarking and performance analytics, enhancing its competitive position in the hospital finance sector [11][12] Company Strategy and Development Direction - CareCloud is transitioning from an ambulatory-first company to one that serves the entire care continuum, integrating inpatient EHR and revenue cycle management [8][9] - The company aims to build an integrated AI-enabled platform that meets the needs of both ambulatory and hospital segments, focusing on operational efficiency and long-term growth [21][30] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's trajectory, highlighting the strategic acquisitions of MedSphere and MapApp as pivotal for future growth [5][13] - The focus remains on profitability, cash flow, and delivering long-term shareholder value, with expectations for continued operational efficiency [32][33] Other Important Information - The company has made significant progress in integrating AI across its platform, with the upcoming launch of the Agentic AI Front Desk Solution expected to enhance patient communication and operational efficiency [16][17] - CareCloud's cash flow from operations for the nine months ended September 30, 2025, was $19.9 million, compared to $15.4 million in the same period last year [30][32] Q&A Session Summary Question: Plans to win new customers and grow sales in the hospital space - Management highlighted the importance of the MedSphere and MapApp acquisitions in establishing credibility and expanding sales opportunities within the hospital market [36][37] Question: Rollout of new AI offerings - The company discussed the evolving AI landscape and its competitive advantages in operational execution and compliance within healthcare [40][42] Question: Competitive landscape and M&A expectations - Management noted that AI is driving M&A conversations, with sellers recognizing the need to integrate AI into their platforms to meet market expectations [48][49] Question: Potential for acquisitions to achieve company margins - Management stated that the goal is to achieve an operating cash flow margin of about 30% or greater for the recent acquisitions, with strong upselling and cross-selling opportunities [58]

Q3 2025 Financial Highlights - Revenue for Q3 2025 increased to $31.1 million, a 9% increase compared to $28.5 million in Q3 2024[18, 32] - Net income remained consistent at $3.1 million in Q3 2025, the same as in Q3 2024[18, 32] - Adjusted EBITDA for Q3 2025 increased to $7.7 million, a 13% increase compared to $6.8 million in Q3 2024[18, 32] - Earnings per share increased by $0.08, from -$0.04 in Q3 2024 to $0.04 in Q3 2025[18, 32] Year-to-Date (YTD) 2025 Financial Highlights - Revenue for YTD 2025 increased to $86.1 million, compared to $82.6 million in YTD 2024[35] - Net income for YTD 2025 increased to $7.9 million, compared to $4.6 million in YTD 2024[35] - Adjusted EBITDA for YTD 2025 increased to $19.9 million, compared to $16.9 million in YTD 2024[35] - Earnings per share increased from -$0.28 in YTD 2024 to $0.07 in YTD 2025[35] - Adjusted net income for YTD 2025 increased to $10.0 million, compared to $6.6 million in YTD 2024[35] Acquisitions - The company closed four acquisitions year-to-date in 2025[20] - Map App was acquired on August 22, 2025, for a purchase price of $16.5 million[21] 2025 Guidance - The company projects revenue between $117 million and $119 million for FY 2025[15] - The company projects adjusted EBITDA between $26 million and $28 million for FY 2025[15] - The company projects earnings per share between $0.10 and $0.13 for FY 2025[15]

Financial Performance - CareCloud reported Q3 2025 revenue of $31.1 million, a 9% increase from $28.5 million in Q3 2024[2] - The company achieved GAAP net income of $3.1 million, maintaining profitability compared to the same quarter last year[2] - Adjusted net income rose by 27% to $4.4 million, up from $3.5 million year-over-year[2] - CareCloud increased its full-year 2025 revenue guidance to $117 – $119 million, up from the previous range of $111 – $114 million[5] - GAAP EPS improved to $0.04, a $0.08 increase from a loss of $0.04 in the same quarter last year[2] - Net revenue for the three months ended September 30, 2025, was $31,067 million, a 5.3% increase from $28,546 million in the same period of 2024[21] - Operating income for the nine months ended September 30, 2025, rose to $8,225 million, compared to $5,665 million in 2024, reflecting a 45.1% increase[21] - Net income attributable to common shareholders for the three months ended September 30, 2025, was $1,695 million, compared to a loss of $667 million in 2024[21] - Adjusted EBITDA for the nine months ended September 30, 2025, was $19,857 million, up from $16,916 million in 2024, representing a 17.3% increase[27] Cash Flow and Investments - CareCloud's cash flow from operations remains strong, allowing for continued payment of preferred stock dividends[4] - Cash provided by operating activities for the nine months ended September 30, 2025, was $19,886 million, compared to $15,413 million in 2024, indicating a 29.5% increase[23] - The company reported a net cash used in investing activities of $21,200 million for the nine months ended September 30, 2025, significantly higher than $5,144 million in 2024[23] - The company ended the period with cash and restricted cash of $5,073 million, up from $2,782 million in 2024[23] Acquisitions and Strategic Growth - The company completed four strategic acquisitions in 2025, enhancing its market presence[3] - The company reduced its line of credit borrowing to $4.9 million from $8.3 million, funding the Medsphere acquisition with a total cash purchase price of $16.5 million[4] Research and Development - Research and development expenses increased significantly to $3,839 million for the nine months ended September 30, 2025, up from $2,768 million in 2024, marking a 38.6% rise[21] Non-GAAP Financial Measures - Management emphasizes the importance of non-GAAP financial measures to understand operational strength and historical trends[37] - Adjusted EBITDA is defined as GAAP net income before taxes, net interest expense, stock-based compensation, and other specified expenses[34] - Non-GAAP adjusted operating income excludes stock-based compensation, amortization of intangible assets, and other costs, providing a clearer view of operational performance[35] - Non-GAAP adjusted net income is calculated by excluding stock-based compensation and other non-recurring items, offering a more accurate reflection of profitability[36] - Management excludes foreign exchange losses and other non-operating expenses from non-GAAP measures as they are not considered part of ongoing operations[38] - Stock-based compensation is treated as a non-cash expense and excluded from operational assessments due to its variability based on external factors[39] - Amortization of purchased intangible assets is not included in operating decisions as it does not reflect ongoing operational performance[40] - Transaction costs related to acquisitions are excluded as they do not correlate with future business operations[41] - Integration costs associated with acquisitions are not considered in operational assessments due to their lack of correlation with future performance[42] - Restructuring costs are excluded from operational evaluations as they are related to optimization efforts rather than ongoing operations[43]

Core Insights - CareCloud, Inc. has raised its full-year 2025 revenue guidance to $117 – $119 million, up from the previous range of $111 – $114 million, reflecting strong financial performance and growth momentum [1][7] - The company reported a 9% year-over-year increase in quarterly revenue, marking its sixth consecutive quarter of positive GAAP net income [1][2] - CareCloud's strategic focus on AI-driven innovation and successful integration of recent acquisitions is enhancing its position in the healthcare technology sector [1][5] Financial Highlights - For the three months ended September 30, 2025, CareCloud reported revenue of $31.1 million, compared to $28.5 million in the same period of 2024, representing a 9% increase [2] - GAAP net income remained stable at $3.1 million, with GAAP EPS improving to $0.04 from a loss of $0.04 in the previous year [2] - Adjusted net income for the quarter was $4.4 million, a 27% increase from $3.5 million in 2024, and adjusted EBITDA rose by 13% to $7.7 million [2] Year-to-Date Performance - For the nine months ended September 30, 2025, total revenue was $86.1 million, up 4% from $82.6 million in 2024 [4] - GAAP net income increased by 74% to $7.9 million, with GAAP EPS improving to $0.07 from a loss of $0.28 [4] - Adjusted net income for the nine months was $10.0 million, a 50% increase from $6.6 million in the previous year [4] Strategic Updates - The company has completed four strategic acquisitions in 2025, including Medsphere, which is expected to broaden its reach in the hospital market [5][6] - CareCloud has established an AI Center of Excellence to drive product innovation and enhance operational efficiency [6] - Management emphasized the synergy between recent acquisitions and AI initiatives, which are expected to create significant value for clients and shareholders [5] 2025 Guidance - CareCloud's updated guidance for 2025 includes revenue expectations of $117 – $119 million, adjusted EBITDA of $26 – $28 million, and EPS of $0.10 - $0.13 [7][8] - The revenue guidance reflects management's expectations regarding contributions from recent acquisitions and organic growth [7]

Core Insights - CareCloud, Inc. will showcase its AI innovations, strategic acquisitions, and growth momentum at the ThinkEquity Conference on October 30, 2025 [1][3] - The company has completed four significant transactions in the year to date, including the acquisition of Medsphere and the addition of HFMA's MAP App, which have enhanced its capabilities and client reach [3] Company Overview - CareCloud specializes in healthcare technology solutions, offering a suite of AI and technology-enabled services aimed at improving financial and operational performance, clinical workflows, and patient experience [4] - The company serves over 40,000 providers, helping them enhance patient care while reducing administrative burdens and operating costs [4]

Group 1 - Preferred shares are typically viewed as fixed income instruments, although they do not appear on the 'Liabilities' section of the balance sheet [1] - Investors utilize these capital market instruments primarily for income generation, with limited potential for capital appreciation [1] - Binary Tree Analytics (BTA) aims to enhance transparency and analytics in capital markets, focusing on Closed-End Funds (CEFs), Exchange-Traded Funds (ETFs), and Special Situations [1] Group 2 - BTA has over 20 years of investment experience, having a background in investment banking cash and derivatives trading [1] - The company seeks to deliver high annualized returns while maintaining a low volatility profile [1]

Core Insights - CareCloud will participate in the 2025 Maxim Growth Summit, focusing on acquisitions, growth, and AI strategy [1] - Maxim Group named CareCloud its 'Top Healthcare IT Pick for 2025' due to its AI strategy, strong financial results, and renewed M&A activity [2] Company Developments - CareCloud has closed four M&A transactions year-to-date, including the acquisition of Medsphere and HFMA's MAP App [9] - The AI Center of Excellence was launched earlier this year and aims to scale to approximately 500 AI professionals to enhance innovation in EHR, RCM, analytics, and patient engagement [9] - Revenue guidance for 2025 has been raised to $116–$118 million, reflecting strong execution [9] - CareCloud has been added to the Russell Microcap Index, which is expected to broaden investor awareness [9] Product and Service Offerings - CareCloud provides a suite of AI and technology-enabled solutions aimed at improving financial and operational performance, streamlining clinical workflows, and enhancing patient experience [5] - The company serves over 40,000 providers, helping them reduce administrative burdens and operating costs [5]

Core Points - CareCloud, Inc. will release its financial results for the third quarter ended September 30, 2025, before the market opens on November 6, 2025 [1] - A conference call for investors will follow at 8:30 a.m. Eastern Time on the same day [1] - The live webcast of the conference call and related presentation slides will be accessible online [2] - An audio-only option for the conference call is available by dialing a specific number [2] - A replay of the conference call will be available approximately three hours after its conclusion [3] Company Overview - CareCloud specializes in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems [1] - The company aims to enhance financial and operational performance, streamline clinical workflows, and improve patient experience [4] - Over 40,000 providers rely on CareCloud's solutions to improve patient care while reducing administrative burdens and operating costs [4]

Core Points - CareCloud, Inc. has declared monthly cash dividends for its Series A and Series B Preferred Stocks for the last quarter of 2025 [1] - The dividends for Series A and Series B are set at 8.75% per annum based on a $25.00 liquidation preference [2][3] Dividend Details - Series A dividend per share for October, November, and December 2025 is $0.18229, with additional payments of $0.04688 for October and $0.01719 for November [2] - Series B dividend per share for the same months is also $0.18229 [2] - Ex-dividend and record dates for all dividends are the last day of each month, with payment dates scheduled for mid-November, mid-December, and mid-January [2][4] Additional Information - Series A Preferred Stock was converted to common stock on March 6, 2025, and holders of these shares will not receive further dividends [3] - The Series B Preferred Stock is still trading on the Nasdaq Global Market under the ticker symbol "CCLDO" [6] - CareCloud's suite of healthcare technology solutions aims to enhance financial and operational performance for over 40,000 providers [8]

Core Insights - CareCloud has announced a definitive agreement to acquire MAP App, a leading hospital benchmarking tool developed by HFMA, which is set to close on October 1, 2025 [1][2] - The acquisition is part of CareCloud's strategy to enhance its SaaS-based ecosystem and expand its AI-driven healthcare technology solutions [2][3] - The partnership with HFMA aims to improve revenue cycle management performance and provide actionable insights for hospitals [3] Company Overview - CareCloud is a leader in AI-driven healthcare technology solutions, serving hospitals, integrated health systems, and medical practices across the United States [1][5] - The company offers a suite of solutions including revenue cycle management, practice management, electronic health records, and patient experience management [5] - More than 40,000 providers rely on CareCloud to enhance patient care while reducing administrative burdens and operating costs [5] Industry Context - MAP App is recognized as an industry-leading tool for benchmarking revenue cycle management performance, utilized by top hospitals and healthcare organizations nationwide [2] - HFMA, the organization behind MAP App, is the leading membership organization for healthcare finance leaders, providing tools and insights to improve financial outcomes in healthcare [3]